Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-061 manufacturers

Filters

None products found

pp-061

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
South Korea
Comments
Indication: Type 2 diabetes mellitus with concurrent hypertension requiring combination oral therapy to improve glycemic control and blood-pressure management. Clinical stage: Phase 3 clinical development. Modality: Small-molecule fixed-dose combination (FDC) Mechanism / Target: Combines two antihyperglycemic and antihypertensive pharmacologic components (specific agents not publicly disclosed) to address dual metabolic and cardiovascular risk factors in T2DM patients. Route / form: Oral formulation. Differentiation: Single-tablet regimen designed to improve treatment adherence in patients requiring both glycemic and blood-pressure control; positioned to simplify chronic management and reduce pill burden versus multi-drug regimens
Manufacturer #38615

A clinical-stage biotech firm developing next-generation nucleotide and small-molecule therapies targeting cancer and other unmet medical needs. It combines proprietary ASO and drug discovery platforms with global development and strategic partnership goals. The organization advances multiple early- to mid-stage programs through clinical and preclinical research.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.